These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27489361)

  • 41. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
    Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
    Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
    Cao J; Yang JC; Ramachandran V; Arumugam T; Deng DF; Li ZS; Xu LM; Logsdon CD
    Cell Physiol Biochem; 2016; 39(2):740-50. PubMed ID: 27459514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
    Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
    Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC.
    Hinzman CP; Aljehane L; Brown-Clay JD; Kallakury B; Sonahara F; Goel A; Trevino J; Banerjee PP
    Carcinogenesis; 2018 Dec; 39(12):1548-1559. PubMed ID: 30165468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein.
    Cheng TY; Yang YC; Wang HP; Tien YW; Shun CT; Huang HY; Hsiao M; Hua KT
    Oncogene; 2018 Mar; 37(13):1730-1742. PubMed ID: 29335522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment.
    Tao J; Gu Y; Zhang Z; Weng G; Liu Y; Ren J; Shi Y; Qiu J; Wang Y; Su D; Wang R; Fu Y; Liu T; Ye L; Luo W; Chen H; Yang G; Cao Z; Huang H; Xiao J; Ren B; You L; Zhang T; Zhao Y
    J Exp Clin Cancer Res; 2024 Oct; 43(1):277. PubMed ID: 39358777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.
    Bermejo-Rodriguez C; Araos Henríquez J; Caligiuri G; Pinto Teles S; Park Y; Evans A; Barrera LN; Neesse A; Grützmann R; Aust D; Rümmele P; Knösel T; Narita M; Narita M; Campbell F; Öhlund D; Pilarsky C; Dow LE; Humbert PO; Biffi G; Tuveson DA; Perez-Mancera PA
    Cancer Res; 2024 Sep; 84(18):2968-2984. PubMed ID: 39037766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9.
    Ma C; Wu B; Huang X; Yuan Z; Nong K; Dong B; Bai Y; Zhu H; Wang W; Ai K
    Tumour Biol; 2014 Dec; 35(12):12729-35. PubMed ID: 25217324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stromal SPOCK1 supports invasive pancreatic cancer growth.
    Veenstra VL; Damhofer H; Waasdorp C; Steins A; Kocher HM; Medema JP; van Laarhoven HW; Bijlsma MF
    Mol Oncol; 2017 Aug; 11(8):1050-1064. PubMed ID: 28486750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
    Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
    Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma.
    Zhang S; Wang H; Mao P; Sun Q; Su H; Zhang Y; Shen S; Xu G; Wang L; Zou X; Zhan Q; Lv Y
    Mol Carcinog; 2023 Aug; 62(8):1176-1190. PubMed ID: 37204217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression.
    Dangi-Garimella S; Strouch MJ; Grippo PJ; Bentrem DJ; Munshi HG
    Oncogene; 2011 Feb; 30(8):1002-8. PubMed ID: 21057545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.